arrow
C

Chiara Rosso

University of Turin
H指数:42
被引数:7,670

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EP497 - ECE_3829 - Evaluating steroid profiles through sexual dimorphism to define metabolic phenotypes and identify advanced fibrosis in patients with MASLD

EP497 - ECE_3829 - 通过性二态性评估类固醇谱以定义代谢表型并识别MASLD患者的进展性肝纤维化

2026-08-100
OAAI
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trial.

体重减轻和超加工食品摄入减少对MASLD患者肝脏脂肪含量的影响:一项随机对照试验

2026-06-220
OA
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study

基于Fibrosis-4和肝脏硬度测量的护理模式对有进展性肝病风险的2型糖尿病患者的筛查有效性:来自一项意大利前瞻性多中心研究的结果

2026-02-014
PRE
Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease

外泌体miRNome谱分析揭示了miRNAs在代谢功能障碍相关脂肪性肝病患者的脂质代谢紊乱、慢性炎症和肝脏损伤中的参与。

2025-04-100
OAAI
Mycobacterium avium Subsp. paratuberculosis and Human Endogenous Retrovirus in Italian Patients With Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)

Mycobacterium avium Subsp. paratuberculosis和Human Endogenous Retrovirus在意大利炎症性肠病(IBD)和肠易激综合征(IBS)患者中的研究

2025-04-040
OAAI
The use of Controlled Attenuation Parameter for the assessment of treatment response in patients with Metabolic Dysfunction- Associated Steatotic Liver Disease undergoing a lifestyle intervention program

使用受控衰减参数评估接受生活方式干预计划的代谢功能障碍相关脂肪性肝病患者的治疗反应

2025-02-010
PRE
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

基于与人类代谢功能障碍相关的脂肪变性肝病 (MASLD) 的接近程度,对小鼠饮食模型进行无偏排名

2024-06-1233
OA